Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products

Core Insights - The biopharmaceutical company is planning to introduce two cancer therapies and an additional HIV treatment option within this year [1] Company Developments - The company is focusing on expanding its product offerings in the oncology and HIV treatment sectors [1]